Surveillance
Purpose
The purposes of this subsection are to establish or continue a Federal initiative to support State and tribal maternal mortality review committees, to improve data collection and reporting around maternal mortality, and to develop or support surveillance systems at the local, State, and national level to better understand the burden of maternal complications and mortality and to decrease the disparities among populations at risk of death and severe complications from pregnancy.
Activities
Prevention research
Purpose
The purpose of this subsection is to provide the Secretary with the authority to further expand research concerning risk factors, prevention strategies, and the roles of the family, health care providers and the community in safe motherhood.
Research
Prevention programs
Maternal mortality review committees
In general
Process for confidential reporting
Data collection and review
Confidentiality
Reports to CDC
State partnerships
States may partner with one or more neighboring States to carry out the activities under this subparagraph. With respect to the States in such a partnership, any requirement under this subparagraph relating to the reporting of information related to such activities shall be deemed to be fulfilled by each such State if a single such report is submitted for the partnership.
Appropriate mechanisms for Indian tribes and tribal organizations
The Secretary, in consultation with Indian tribes, shall identify and establish appropriate mechanisms for Indian tribes and tribal organizations to demonstrate, report data, and conduct the activities as required for participation in the program described in this subsection. Such mechanisms may include technical assistance with respect to grant application and submission procedures, and award management activities.
Research availability
The Secretary shall develop a process to ensure that data collected under paragraph (5) is made available, as appropriate and practicable, for research purposes, in a manner that protects individually identifiable or potentially identifiable information and that is consistent with State and Federal privacy law.
Definitions
Authorization of appropriations
For the purpose of carrying out this section, there are authorized to be appropriated $58,000,000 for each of fiscal years 2019 through 2023.
July 1, 1944, ch. 373Pub. L. 106–310, div. A, title IX, § 901114 Stat. 1125Pub. L. 115–344, § 2132 Stat. 5047Pub. L. 117–103, div. P, title I, § 141(c)136 Stat. 798(, title III, § 317K, as added , , ; amended , , ; , , .)
Editorial Notes
Amendments
Pub. L. 117–103, § 141(c)(1)2022—Subsec. (a)(2)(A). , inserted before period at end “, including improving disaggregation of data (in a manner consistent with applicable State and Federal privacy laws)”.
Pub. L. 117–103, § 141(c)(2)Subsec. (b)(2)(M), (N). , added subpar. (M) and redesignated former subpar. (M) as (N).
Pub. L. 115–344, § 2(1)(A)2018—Subsec. (a)(1). , substituted “purposes of this subsection are to establish or continue a Federal initiative to support State and tribal maternal mortality review committees, to improve data collection and reporting around maternal mortality, and to develop or support” for “purpose of this subsection is to develop” and “populations at risk of death and severe” for “population at risk of death and”.
Pub. L. 115–344, § 2(1)(B)(i)Subsec. (a)(2)(A). , amended subpar. (A) generally. Prior to amendment, subpar. (A) read as follows: “The Secretary may establish and implement a national surveillance program to identify and promote the investigation of deaths and severe complications that occur during pregnancy.”
Pub. L. 115–344, § 2(1)(B)(ii)Subsec. (a)(2)(D). , added subpar. (D).
Pub. L. 115–344, § 2(2)(A)Subsec. (b)(2)(A). , substituted “prepregnancy” for “encouraging preconception” and “women with diabetes and women with substance use disorder” for “diabetics”.
Pub. L. 115–344, § 2(2)(B)Subsec. (b)(2)(H). , inserted “the identification of the determinants of disparities in maternal care, health risks, and health outcomes, including” before “an examination” and “and other groups of women with disproportionately high rates of maternal mortality” before semicolon at end.
Pub. L. 115–344, § 2(2)(E)Subsec. (b)(2)(I). , added subpar. (I). Former subpar. (I) redesignated (J).
Pub. L. 115–344, § 2(2)(C), substituted “interpersonal” for “domestic”.
Pub. L. 115–344, § 2(2)(D)Subsec. (b)(2)(J). , redesignated subpar. (I) as (J). Former subpar. (J) redesignated (K).
Pub. L. 115–344, § 2(2)(D)Subsec. (b)(2)(K). , (F), redesignated subpar. (J) as (K) and substituted “and substance abuse and misuse” for “, alcohol and illegal drug use”. Former subpar. (K) redesignated (L).
Pub. L. 115–344, § 2(2)(D)Subsec. (b)(2)(L), (M). , redesignated subpars. (K) and (L) as (L) and (M), respectively.
Pub. L. 115–344, § 2(3)(A)Subsec. (c). , (B), struck out par. (1) designation and heading “In general” before “The Secretary” and redesignated subpars. (A) to (C) of former par. (1) as pars. (1) to (3), respectively. Amendment was executed to reflect the probable intent of Congress notwithstanding minor error in quoted par. (1) heading in original text directed to be struck out.
Pub. L. 115–344, § 2(3)(C)Subsec. (c)(1). , struck out “and the building of partnerships with outside organizations concerned about safe motherhood” after “pregnancies”.
Pub. L. 115–344, § 2(3)(D)Subsec. (c)(4). –(F), added par. (4).
Pub. L. 115–344, § 2(5)Subsecs. (d), (e). , added subsecs. (d) and (e). Former subsec. (d) redesignated (f).
Pub. L. 115–344, § 2(4)Subsec. (f). , (6), redesignated subsec. (d) as (f) and substituted “$58,000,000 for each of fiscal years 2019 through 2023” for “such sums as may be necessary for each of the fiscal years 2001 through 2005”.